Literature DB >> 7826610

Mycoplasma contamination of chlamydiae isolated from clinical specimens.

T O Messmer1, C M Black, W L Thacker.   

Abstract

Ten Chlamydia pneumoniae strains were screened for Mycoplasma contamination using two differently designed Mycoplasma-specific polymerase chain reactions (PCR). The primers of the Mycoplasma-specific PCR designed by Spaepen et al. (9) cross-reacted with all of the C. pneumoniae strains giving false-positive results. When the 10 strains of C. pneumoniae were tested for mycoplasmas with the PCR designed by Harasawa et al. (5), only 3 were positive. Mycoplasmas were cultured from these three C. pneumoniae strains confirming the latter PCR results. The PCR of Harasawa et al. (5) was highly specific for mycoplasmas and did not cross-react with C. pneumoniae. These findings suggest that chlamydiae should be periodically screened for Mycoplasma contamination. Careful attention to primer design is important if PCR is chosen as the screening method.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7826610     DOI: 10.1111/j.1699-0463.1994.tb05236.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  9 in total

1.  Mycoplasma fermentans, M. hominis, and M. hyorhinis inhibit infectivity and growth of Chlamydia trachomatis and C. pneumoniae in HEp-2 cells.

Authors:  B Krausse-Opatz; P Dollmann; H Zeidler; L Köhler; J G Kuipers
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

2.  Effect of a Mycoplasma hominis-like Mycoplasma on the infection of HEp-2 cells by the TW-183 strain of Chlamydia pneumoniae.

Authors:  E A Castilla; R M Wadowsky
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

3.  Sequence homologies between Mycoplasma and Chlamydia spp. lead to false-positive results in chlamydial cell cultures tested for mycoplasma contamination with a commercial PCR assay.

Authors:  Viola Maass; Jan Marco Kern; Matthias Poeckl; Matthias Maass
Journal:  J Clin Microbiol       Date:  2011-08-17       Impact factor: 5.948

4.  Infection of human monocyte-derived macrophages with Chlamydia trachomatis induces apoptosis of T cells: a potential mechanism for persistent infection.

Authors:  M C Jendro; T Deutsch; B Körber; L Köhler; J G Kuipers; B Krausse-Opatz; J Westermann; E Raum; H Zeidler
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

5.  Cytokine expression pattern in the genital tract of Chlamydia trachomatis positive infertile women - implication for T-cell responses.

Authors:  B S Reddy; S Rastogi; B Das; S Salhan; S Verma; A Mittal
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

6.  Application of a Mycoplasma group-specific PCR for monitoring decontamination of Mycoplasma-infected Chlamydia sp. strains.

Authors:  J M Ossewaarde; A de Vries; T Bestebroer; A F Angulo
Journal:  Appl Environ Microbiol       Date:  1996-02       Impact factor: 4.792

7.  In vitro activities of garenoxacin and levofloxacin against Chlamydia pneumoniae are not affected by presence of Mycoplasma DNA.

Authors:  Raymond P Smith; Aldona L Baltch; William J Ritz; Andrea N Carpenter; Tanya A Halse; Lawrence H Bopp
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

8.  A multi-laboratory profile of Mycoplasma contamination in Lawsonia intracellularis cultures.

Authors:  Jeong-Min Hwang; Ji-Hye Lee; Jung-Yong Yeh
Journal:  BMC Res Notes       Date:  2012-01-27

9.  Elimination of Mycoplasma contamination in Chlamydia stocks as a result of in vivo passage or plaque isolation.

Authors:  Ira M Sigar; Justin H Schripsema; Kathleen A Kelly; Ashlesh K Murthy; Srikanth Manam; Kyle H Ramsey
Journal:  BMC Res Notes       Date:  2018-06-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.